Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Feb 16, 2017; 9(2): 61-69
Published online Feb 16, 2017. doi: 10.4253/wjge.v9.i2.61
Table 2 Association among indications and gastric intestinal metaplasia
Frequency in patients with gastric IM1Frequency in patients without gastric IM1Univariate analysisMultivariate analysis
[OR (95%CI)]
Abdominal pain188 (41.7%)93 (54.4%)P = 0.0050.81 (0.55, 1.18), P = 0.267
Weight loss63 (13.5%)21 (7.4%)P = 0.0141.81 (0.95, 3.66), P = 0.073
GI bleed38 (8.4%)13 (7.6%)P = 0.7551.23 (0.63, 2.52), P = 0.558
Nausea60 (13.3%)27 (15.8%)P = 0.4260.97 (0.58, 1.65), P = 0.903
Dysphagia59 (13.1%)26 (15.2%)P = 0.4900.74 (0.44, 1.26), P = 0.259
Barrett’s esophagus10 (2.2%)8 (4.7%)P = 0.1230.32 (0.12, 0.92), P = 0.034